BeiGene, a global, science-driven biotechnology company, announced the opening of a new site for global developing & manufacturing of small molecule innovative medicines in Suzhou, East China’s Jiangsu Province on November 16. In an exclusive interview, SVP and Global Head of Technical Operations and Manufacturing of BeiGene Dr. Kyu-Sung Lee shared with Global Times his personal stories and elaborated his passion about benefiting patients around the world with innovative medicines, with BeiGene expanding its global manufacturing footprint starting in China.